PACIRA BIOSCIENCES, INC. (PCRX) Total liabilities 2016–2025
PACIRA BIOSCIENCES, INC. (PCRX) total liabilities at each fiscal year-end, per SEC filings.
$571.8MFY2025 · since FY2016: $172.5M → $571.8M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | $571.8M | -26.2% |
| FY2024 | $775.2M | +10.1% |
| FY2023 | $704.3M | -22.3% |
| FY2022 | $906.2M | -32.6% |
| FY2021 | $1.3B | +105.4% |
| FY2020 | $654.8M | +37.5% |
| FY2019 | $476.1M | +29.3% |
| FY2018 | $368.1M | +5.5% |
| FY2017 | $348.9M | +102.3% |
| FY2016 | $172.5M | — |
Years the filer does not tag total liabilities directly are shown as reported total assets − reported shareholders’ equity at the same fiscal year-end.
Source: SEC XBRL filings · For reference only · Not investment advice